Skip to Content

APO C300 (Carbamazepine extended-release 300 mg)

Pill imprint APO C300 has been identified as Carbamazepine extended-release 300 mg.

Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbamazepine extended-release 300 mg APO C300
Carbamazepine extended-release 300 mg APO C300
Carbamazepine extended-release 300 mg APO C300
Carbamazepine extended-release
Imprint:
APO C300
Strength:
300 mg
Color:
White / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide